FluoroPharma and Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial
MONTCLAIR, NJ--(Marketwired - October 18, 2016) - FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that it has been collaborating with Philips for data management in conjunction with its Phase II clinical trials for its lead agent CardioPET (18-F …